Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,000
Closed -$1.14M 863
2020
Q3
$1.14M Hold
1,000
0.33% 67
2020
Q2
$933K Hold
1,000
0.25% 90
2020
Q1
$155K Buy
+1,000
New +$15.3K 0.04% 229
2018
Q1
Sell
-200
Closed -$400 657
2017
Q4
$400 Hold
200
﹤0.01% 513
2017
Q3
$8.86K Buy
+200
New +$2.89K ﹤0.01% 401

Other funds holding SNAP

Exane Derivatives's SNAP Position: Q2 2022 in Review

Exane Derivatives reduced its Snap (SNAP) stake by 63% in Q2 2022, selling an estimated $71.1K and leaving 1,831 shares worth $24K. The position accounts for 0.01% of the portfolio, ranked #356.

Exane Derivatives first reported a position in SNAP in Q1 2017 and has held it in 22 quarters since. The position peaked at $2.01M in Q1 2020. 627 funds tracked by Wall St. Rank hold SNAP as of Q2 2022.

  • Exane Derivatives held 1,831 shares of Snap worth $24K as of Q2 2022.
  • Exane Derivatives sold 3,117 Snap shares in Q2 2022, an estimated $71.1K.
  • Snap made up 0.01% of Exane Derivatives's portfolio in Q2 2022, its #356 holding.
  • Exane Derivatives first reported a position in Snap in Q1 2017 and has held it in 22 quarters since.
  • Exane Derivatives's Snap position peaked at $2.01M in Q1 2020.
  • 627 funds tracked by Wall St. Rank held Snap as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.